35.37 USD
▼-3.72-9.52%
盘后 35.72 +0.99%
2026-09-15
市值
$884.78M
市盈率
—
EPS
-82.46
股息率
—
52 周区间
7.45 – 42.14
成交量
209.05K
Beta
-0.28
目标价
54.64
52W 低 7.4552W 高 42.14
价格走势
公司简介
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early ...